The Indian equity market extended its winning streak to third consecutive week amid better than expected monsoon, strengthening Indian currency and... ...http://www.indiainfoline.com/article/news-top-story/weekly-3rd-consecutive-week-of-gains-for-sensex-nifty-115070300418_1.html
In a chat with ET Now, Prakash Gaba, CFT, prakashgaba.com, shares his view on Natco Pharma. ET Now: What is your view on Natco Pharma? Prakash... ...http://economictimes.indiatimes.com/markets/stocks/recos/buy-natco-pharma-with-a-target-of-rs-2400-prakash-gaba/articleshow/47893321.cms
The market has moved from strength-to-strength in the morning deals, on the back of fresh rally across all sectors. Buying is clearly evident in... ...http://www.indiainfoline.com/article/news-top-story/sensex-nifty-strengthen-further-capital-goods-pharma-stocks-gain-115070100261_1.html
After moving in a tight range amid cautious trades till around mid afternoon, Indian stocks ended on a firm note on Tuesday with investors... ...http://www.sify.com/finance/sensex-ends-136-pts-up-news-sensex-pg4rqSjjfajgb.html
The market remains deep down in negative territory although a few front line stocks have regained a bit of lost ground thanks to modest support at... ...http://www.sify.com/finance/sensex-down-408-pts-tech-mahindra-plunges-nearly-8-news-sensex-pg3oLngjaddee.html
Erlonat (Erlotinib) is a Kinase...